Peter Wehrwein

In this week's episode of "Tuning In to the C-Suite" podcast, Senior Editor Peter Wehrwein spoke with Debra Cooper, RN, MSN, MBA/HCM, a senior risk specialist at Coverys, a medical malpractice insurance company headquartered in Boston. Wehrwein and Cooper discussed the role the company has played in advising providers during the COVID-19 pandemic, risk mitigation, and the role they can now play in overcoming vaccine hesitancy.

The FDA approved proton beam radiation in 1988. But whether it is an improvement over conventional photon radiation as a treatment for many cancers remains an open question.

Brooks, senior medical director of Independence Blue Cross in Philadelphia, was a key member of the team that created a health awareness campaign launched earlier this month in cooperation with local radio station WURD and other partners including the Colorectal Cancer Alliance, the Independence Blue Cross Foundation, Penn Medicine, Labcorp, and the Health Care Improvement Foundation. The campaign, called “Go To Know,” sets out to increase colon cancer screenings among African Americans by providing free Fecal immunochemical, or FIT, tests.

In this second part of a three-part series, Steven D. Pearson, M.D., M.Sc., founder and president of ICER addresses if pricing of PCSK9 inhibitors put ICER on the map.

In this new episode of MHE Talks: Improving Patient Access podcast, Steven D. Pearson, M.D., M.Sc., warns that high prices can squander an opportunity to bring innovative medications into clinical use.

Nod from FDA comes as drugmakers are withdrawing indications for cancer drugs that were also approved an accelerated basis.

Most are in the riskier global risk track with 100% savings and losses.

In this final video of a four-part video series, Signify Health senior vice president of Episodes of Care, François de Brantes, speaks with Managed Healthcare Executive about value-based care, the toxic incentives in healthcare, how the Direct Contracting Model differs from Medicare Advantage and more.

In this third of a four-part video series, Signify Health senior vice president of Episodes of Care, François de Brantes, speaks with Managed Healthcare Executive about value-based care, the toxic incentives in healthcare, how the Direct Contracting Model differs from Medicare Advantage and more.

Diagnoses spike in people's 65th year when most Americans become newly eligible for Medicare coverage.

In this second of a four-part video series, Signify Health senior vice president of Episodes of Care, François de Brantes, speaks with Managed Healthcare Executive about value-based care, the toxic incentives in healthcare, how the Direct Contracting Model differs from Medicare Advantage and more.

Samitt announced he is retiring after three years at the helm of the Minnesota Blues plan.

In this first of a four-part video series, Signify Health senior vice president of Episodes of Care, François de Brantes, speaks with Managed Healthcare Executive about value-based care, the toxic incentives in healthcare, how the Direct Contracting Model differs from Medicare Advantage and more.

In this month's episode of the Meet the Board podcast series, MHE spoke with Signify Health's Senior Vice President of Episodes of Care, François de Brantes. In the discussion de Brantes touched on a few facts about himself, he shared the toxic incentives in healthcare, how the Direct Contracting Model differs from Medicare Advantage and more.

Insurers might benefit from increase in the number of beneficiaries in their Medicare Advantage plans.

The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.

In this final part of a two-part video series, Senior Editor Peter Wehrwein spoke with Vayong Moua, the Director of Racial and Health Equity Advocacy for Blue Cross and Blue Shield of Minnesota (BCBSMN), about healthcare equity issues, how they relate to access issues, the political determinants of health and killing of George Floyd.

In this first part of a two-part video series, Senior Editor Peter Wehrwein spoke with Vayong Moua, the Director of Racial and Health Equity Advocacy for Blue Cross and Blue Shield of Minnesota (BCBSMN), about healthcare equity issues, how they relate to access issues, the political determinants of health and killing of George Floyd.

Senior Editor Peter Wehrwein spoke with Vayong Moua, the Director of Racial and Health Equity Advocacy for Blue Cross and Blue Shield of Minnesota (BCBSMN), for this week's episode of the "MHE Talks: Improving Patient Access" podcast series. Wehrwein and Moua discussed healthcare equity issues, how they relate to access issues, the political determinants of health and killing of George Floyd.

Founder and CEO of a leading care coordination technology company discusses the buzz about the new Direct Contracting Model.

Governments are the only buyers so far, and the amounts they are paying varies.

Population-level study of Medicare beneficiaries shows marked improvement in survival statistics but also an 8.6% jump in Medicare spending.

Patient centricity and physician leadership were among the keys of success of a program that increased the proportion of same-day total hip and knee replacement from 7.2% to 62% in a span of three years.

In a short address, Broussard also discussed Humana's success in the Medicare Advantage program and expanding access to healthcare.